Cytological analysis
of glycogen-rich carcinoma of the breast:report of two cases
Nobuo Satake*, Hisanori Uehara*,
Nobuya Sano†, Takayuki Kubo†,
Mitsunori Sasa‡, and Keisuke Izumi*
|
*Department of Molecular and Environmental
Pathology, †Division of Surgical Pathology, University
Hospital, The University of Tokushima School of Medicine,
Tokushima, Japan;and ‡Director of Tokushima Breast
Care Clinic, Tokushima, Japan
Abstract: Background:Glycogen-rich carcinoma is a rare special
histologic subtype of breast cancer and its incidence is estimated
to be1.4% in breast malignancies. However, its precise characteristics
in cytological specimens have not yet been fully clarified.
Case:Fifty-nine-year-old and 53-year-old women underwent fine-needle
aspiration biopsy cytology (FNABC) of a breast tumor, confirming
malignancy. A mastectomy with axillary dissection was performed.
Cytologically, a moderate amount of eosinophilic, finely granular
cytoplasm was seen in the majority of the tumor cells, however,
foamy and vacuolated cytoplasm was noted in some tumor cells.
Histologically, the tumor cells of both cases had clear and
granular cytoplasm, which showed a positive reaction with
periodic acid-Schiff, eliminated by diastase.
Conclusion:While clear cytoplasm in the tumor cells in the
FNABC seemed to be a pivotal cytological characteristic of
glycogen-rich carcinoma, it may not be a major component of
cytological specimens. Routine periodic acid-Schiff staining
may be required to diagnose glycogen-rich carcinoma in cytological
methods. J. Med. Invest. 49:193-196, 2002
Keywords:breast, fine-needle aspiration biopsy cytology, glycogen-rich
carcinoma, c-erbB-2, cytology
INTRODUCTION
Glycogen-rich carcinoma (GRC) is a rare special histologic
subtype of breast cancer, comprising1.4% of breast malignancies(1).
The clear cytoplasm observed in histological specimens is
caused by the extraction of water-soluble glycogen during
histological processing. We reviewed the cytological findings
in two cases, which were histologically diagnosed by surgically
resected specimens.
CASE REPORT
Case1:A59-year old woman had complained of a bloody nipple
discharge and a palpable mass in her right breast for three
months. Case2:A53-year old woman had noticed a mass in her
left breast, and the tumor had gradually enlarged. They visited
Tokushima Breast Care Clinic and received ultrasonography
and mammography. Fine-needle aspiration biopsy cytology (FNABC)
revealed malignant cells from their lesions. A mastectomy
with axillary dissection was performed at another institution.
CYTOLOGICAL FINDINGS
On a hemorrhagic background, small clusters of atypical cells
were identified in both cases. The tumor cells had a high
N/C ratio and large and polygonal nuclei with prominent nucleoli
(Figs. 1A-1D). A moderate amount of eosinophilic, finely granular
cytoplasm was observed in most of the tumor cells. However,
some were rich in foamy and vacuolated cytoplasm. Mitotic
figures were infrequent.
MACROSCOPIC FINDINGS
The tumor of Case1 consisted of many solid and whitish yellow
nodules measuring a maximum of1cm. Some nodules were noted
to extend into the surrounding adipose tissue. The gross findings
of Case2 did not differ from those of the usual invasive carcinoma
of the breast. The tumor measured 2.5× 2.3×2.0cm,
a whitish-yellow solitary mass with irregular margins. Necrosis,
bleeding and infarction were not prominent in either case.
HISTOLOGICAL AND IMMUNOHISTOCHEMICAL FINDINGS
The following stains and immunohistochemical examinations
were performed:hematoxylin and eosin (HE), periodic acid-Schiff
(PAS) with and without diastase pretreatment, alcian blue,
mucicarmine;Cam5.2 (cytokeratin) (BECTON, prediluted) , AE1/AE3
(cytokeratin) (DAKO ×50), epithelial membrane antigen
(EMA) (clone:E29;DAKO, ×100), desmin (DAKO, ×50),
vimentin (DAKO, ×150), carcinoembryonic antigen
(CEA) (polyclonal;DAKO, ×50), estrogen receptor
(DAKO, ×50) and c-erbB-2 (clone:AO485;DAKO, ×800).
Immunohistochemical staining was carried out with DAKO LSAB
kit.
The tumor cells of both cases had mostly clear and granular
cytoplasm, small and hyperchromatic nuclei and prominent nucleoli
(Figs. 1E-1G). The cytoplasmic granular staining by PAS was
abolished by pretreatment with diastase. The tumors showed
both intraductal and invasive growth patterns. Although a
comedo pattern was evident in both cases, no cribriform pattern
was observed in either of the cases. Alcian blue and mucicarmine
failed to show mucus in the tumor cells in either case. The
tumor had four and seventy mitotic figures per 10 high power
fields (HPFs) in Cases1 and 2, respectively.
Immunohistochemically, the tumor cells in both cases were
positive for Cam5.2, AE1/AE3, but negative for vimentin, desmin
and estrogen receptor. CEA was weakly positive in Case1, but
negative in Case2. Faint or barely perceptible membrane staining
of c-erbB-2 in more than 10% of the tumor cells was observed
in both cases (Fig. 1H).
DISCUSSION
GRC of the breast, a rare histologic subtype originally reported
by Hull et al. in1981, is defined when 90% or more tumor cells
have clear cytoplasm containing glycogen in histological specimens
(2-4). Histologically, our cases were consistent with the
difinition. In the records of Tokushima Breast Care Clinic,
between 1996 and 2001, two of 217 (0.9percent) cases of breast
carcinoma were GRC.
Although rare, the cytologic findings of GRC have been described
in a few case reports. Satoh et al. reported that tumor cells
with various nuclear atypia, small round or ovoid nuclei and
abundant, clear cytoplasm were identified in FNABC(4). Borislav
et al. reported that papillary cell groups and single tall
columnar cells with apical cytoplasmic projections were contained
in the aspirate(5). Although foamy and vacuolated cytoplasm
could be seen in some tumor cells, we diagnosed both cases
as `simple' adenocarcinoma. With the PAS reaction, the accumulation
of glycogen may be easily demonstrated by cytology. In our
laboratory, routine cytological screening of aspiration biopsies
of the breast has been performed only by standard Papanicolaou
staining.
The differential diagnosis of GRC includes mammary carcinomas
with clear or vacuolated cytoplasm, and lipid rich carcinoma.
The presence of lipid cannot be demonstrated by cytology because
aspiration biopsy smears were immediately fixed in95% ethanol.
The presence of lipid can be demonstrated in frozen sections
of fresh tissue or electron microscopy.
The prognosis of glycogen-rich carcinoma were described in
many reports. In the reported cases, 14 of 35patients (forty
percents) of invasive glycogen-rich carcinomas died. Metastasis
in the lymph nodes were observed in 17patients (49percents).
The prognosis of glycogen-rich carcinoma were reported to
be worse(6). The patients of case1 and 2 are now well and
post-operative regular checkup are necessary.
The c-erbB-2 (HER2/neu) proto-oncogene encodes a receptor
protein with a tyrosine kinase domain that shows extensive
homology with epidermal growth factor receptor (EGFR) (7,
8). HER2/neu proto-oncogene is amplified in25to30%of primary
breast carcinomas(9) and HER2/neu overexpression is associated
with a more aggressive potential and shortened survival(10).
As far as we know, the immunohistochemical features of c-erbB-2
proto-oncogene in GRC have not been reported.
Estrogen receptor (ER) plays an important role in the biology
of breast cancer and is accepted as a good prognostic marker.
Estrogen receptor was positive in the case reported by Hull
et al. (2) and among four invasive carcinoma cases reported
by Hayes et al., two cases were positive and the other two
were negative(11). The positive rate of ER in15cases reported
by Fujino et al. was 53%(6).However, the tumor cells were
negative for ER in our two cases.
In summary, it may be difficult to diagnose GRC by FNABC,
particularly when the cytological specimens are processed
promptly. Clear cell changes caused by glycogen and other
substances are often observed histologically in ordinary intraductal
and invasive ductal carcinomas. Since there was a poorer overall
prognosis for GRC than for ordinary ductal carcinoma and the
prominent features could not be detected by ultrasound examination
and mammography, diagnosing GRC in cytological specimens may
be of significance. In this concern, PAS reaction (with or
without diastase digestion) in addition to the standard Papanicolaou
stain may be necessary in routine cytological screening of
aspiration biopsies of the breast.
ACKNOWLEDGEMENTS:
We are grateful to Kumiko Fujii, Toshio Yamaguchi (Department
of Molecular and Environmental Pathology, The University of
Tokushima School of Medicine), Aki Katsura (Division of Surgical
Pathology, University Hospital, The University of Tokushima
School of Medicine) for technical assistance.
REFERENCES
1.Rosen PP, Obermann H:Tumors of the mammary gland. Atlas
of tumor pathology. Vol.7.Armed Forces Institute of Pathology,
Washington, DC, 1993, pp. 240-242
2.Hull MT, Priest JB, Broadie TA, Ransburg RC, McCarthy LJ:Glycogen-rich
clear cell carcinoma of the breast:alight and electron microscopic
study. Cancer48:2003-2009, 1981
3.Toikkanen S, Joensuu H:Glycogen-rich clear-cell carcinoma
of the breast:a clinicopathologic and flowcytometric study.
Human Pathology22:81-83, 1991
4.Satoh F, Umemura S, Itoh H, Miyajima Y, Tokuda Y, Tajima
T, Osamura RY:Fine needle aspiration cytology of glycogen-rich
clear cell carcinoma of the breast. A case report. Acta Cytol
42:413-418, 1998
5.Alexiev BA:Glycogen-rich clear cell carcinoma of the breast:report
of a case with fine-needle aspiration cytology and immunocytochemical
and ultrastructural studies. Diagn Cytopathol 12:62-66, 1995
6.Fujino S, Tezuka N, Sawai S, Konishi T, Inoue S, Kato H,
Mori A, Okabe H:Glycogen-rich Clear Cell Carcinoma of the
Breast:A Case Report and Review of the Literature. Breast
Cancer 3:205-208, 1996
7.King CR, Kraus MH, Aaronson SA:Amplification of a novel
v-erbB-related gene in a human mammary carcinoma. Science
229:974-976, 1985
8.Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima
N, Saito T, Toyoshima K:Similarity of protein encoded by the
human c-erb-B-2gene to epidermal growth factor receptor. Nature
319:230-234, 1986
9.Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith
DE, Levin WJ, Stuart SG, Udove J, Ullrich A, Press MF:Studies
of the HER-2/neu proto-oncogene in human breast and ovarian
cancer. Science 244:707-712, 1989
10.Tsuda H, Hirohashi S, Shimosato Y, Hirota T, Tsugane S,
Yamamoto H, Miyajima N, Toyoshima K, Yamamoto T, Yokota J,
Yoshida T, Sakamoto H, Terada M, Sugimura T:Correlation between
long-term survival in breast cancer patients and amplification
of two putative oncogene-coamplification units:hst-1/int-2
and c-erbB-2/ear-1. Cancer Res 49:3104-3108, 1989
11.Hayes MMM, Seidman JD, Ashton MA:Glycogen-rich clear cell
carcinoma of the breast. A clinicopathologic study of21cases.
Am J Surg Pathol 19:904-911, 1995
Received for publication June 14, 2002;accepted July 11, 2002.
Address correspondence and reprint requests to Nobuo Satake,
Department of Molecular and Environmental Pathology, The University
of Tokushima School of Medicine, Kuramoto-cho, Tokushima770-8503,
Japan and Fax:+81-88-633-7067.
|
| |